Health Care & Life Sciences » Biotechnology | Proteome Sciences PLC

Proteome Sciences PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,372.50
3,993.50
3,326.00
2,943.00
2,053.00
1,659
Depreciation, Depletion & Amortization
167.80
407.00
395.00
553.00
332.00
229
Other Funds
71.60
878.10
848.00
948.00
313.00
1,064
Funds from Operations
3,276.30
2,708.40
2,083.00
1,442.00
1,408.00
366
Changes in Working Capital
511.00
553.30
270.00
551.00
289.00
138
Net Operating Cash Flow
2,765.30
3,261.70
2,353.00
1,993.00
1,697.00
504
Capital Expenditures
9.20
155.30
52.00
33.00
23.00
Net Investing Cash Flow
9.20
155.30
52.00
33.00
23.00
Issuance/Reduction of Debt, Net
1,000.00
-
55.00
220.00
220.00
Net Financing Cash Flow
2,556.20
4,793.90
2,333.00
2,908.00
197.00
Net Change in Cash
258.00
1,268.40
61.00
1,076.00
1,976.00
Free Cash Flow
2,774.50
3,417.00
2,405.00
2,026.00
1,720.00
Change in Capital Stock
1,556.20
4,793.90
2,388.00
3,128.00
23.00
Exchange Rate Effect
39.70
108.50
11.00
194.00
59.00

About Proteome Sciences

View Profile
Address
Hamilton House
London Greater London WC1H 9BB
United Kingdom
Employees -
Website http://proteomics.com
Updated 07/08/2019
Proteome Sciences Plc is engaged in applied proteomics and peptidomics services and applications. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection.